Cancer Biology & Medicine Open Access Editor-in-Chief: Xishan Hao
Home Cancer Biology & Medicine All Issues Volume 23 Issue 6
Volume 23 Issue 6, June 2026
Cover
Cover
PP. 785-950
|
10 articles
Previous Issue
|
Next Issue
EDITORIAL
Editorial | Open Access
From overtreatment to precision: a new clinical standard for DCIS management
Schlomo Schneebaum
Published: 19 March 2026
2026, 23(6): 785-787
PERSPECTIVE
Perspective | Open Access
Toward the precision use of Chinese PARP inhibitors in ovarian cancer: clinical progress, resistance mechanisms, and future perspectives
Jing Yu, Maochen Li, Yuhan Zhu, [...], Shengnan Wang, Yuzhao Jiang, Wei Cui, Lingying Wu << Fewer
Published: 01 June 2026
2026, 23(6): 788-795
CONSENSUS
Consensus | Open Access
Chinese expert consensus on additional surgery following endoscopic resection for early colorectal cancer (2025 edition)
Zhipeng Qi, Fuqiang Zhao, Xuhua Hu, [...], Yunshi Zhong, Qian Liu, Zhongtao Zhang, Guiying Wang << Fewer
Published: 18 March 2026
2026, 23(6): 796-809
REVIEW
Review | Open Access
Metabolic regulation of tumor-associated macrophage function and immunotherapy in cancer
Mingyue Zhao, Rui Chen, Ping Gao
Published: 13 April 2026
2026, 23(6): 810-832
Review | Open Access
Drug resistance to antibody-drug conjugates: mechanisms, challenges, and perspectives
Yajing Liu, Yuwei Liu, Tingting Wu, [...], Xiaoming Bai, Shuman Wang, Luyun Zhang, Zhiwen Fu, Chen Shi << Fewer
Published: 06 April 2026
2026, 23(6): 833-864
Review | Open Access
Opportunities and challenges of immunotherapy for patients with resectable and potentially resectable stage Ⅲ non-small cell lung cancer
Yuzhen Cui, Jingdong Xu, Junxu Wen, [...], Jianfeng Peng, Jiangao Ren, Ailing Liu, Xiangjiao Meng, Zhaoqin Huang, Anwen Liu << Fewer
Published: 21 April 2026
2026, 23(6): 865-887
ORIGINAL ARTICLE
Original Article | Open Access
HBx-mediated GPT2 suppression promotes liver cancer development by downregulating ADH1A
Hongjuan You, Xing Wang, Ruyu Liu, [...], Yuxin Wang, Huanyang Zhang, Lihong Ma, Ensi Bao, Yujie Zhong, Xiangye Liu, Delong Kong, Xiucheng Pan, Xiaocui Li, Suping Qin, Kuiyang Zheng, Chen Li, Renxian Tang, Fanyun Kong << Fewer
Published: 19 May 2026
2026, 23(6): 888-909
Original Article | Open Access
Expansion of IL-2-independent tumor-infiltrating lymphocytes through a feeder-free process: a preclinical study for solid tumors
Ying Zhang, Sicheng Du, Rongrui Liu, [...], Chuanhua Zhao, Juan Li, Sisi Ye, Man Zhang, Xingming Ma, Zhou He, Wenjia Zhuang, Huajun Jin, Jianming Xu << Fewer
Published: 05 March 2026
2026, 23(6): 910-924
Original Article | Open Access
Cancer-immunity cycle-based molecular subtypes in breast cancer predict the response to immune checkpoint inhibitors
Di Shao, Tianjian Yu, Yi Xiao, Zhiming Shao
Published: 05 March 2026
2026, 23(6): 925-945
LETTER
Letter | Open Access
Sequential nimotuzumab plus gemcitabine and nab-paclitaxel chemotherapy followed by irreversible electroporation in advanced pancreatic ductal adenocarcinoma: a retrospective real-world analysis
Yang Liu, Dandan Wu, Xing Li, [...], Xihao Zhang, Rentao Li, Yanmei Ou, Hao Wang, Tongguo Si, Rui Xia, Yong Xu, Huikai Li, Chuntao Gao, Jihui Hao << Fewer
Published: 16 March 2026
2026, 23(6): 946-950